Compare DDS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DDS | RVTY |
|---|---|---|
| Founded | 1938 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 9.9B |
| IPO Year | N/A | N/A |
| Metric | DDS | RVTY |
|---|---|---|
| Price | $691.99 | $98.55 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $511.33 | $112.31 |
| AVG Volume (30 Days) | 131.1K | ★ 1.7M |
| Earning Date | 11-13-2025 | 01-30-2026 |
| Dividend Yield | ★ 4.58% | 0.28% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 36.93 | 1.99 |
| Revenue | ★ $6,625,563,000.00 | $2,813,367,000.00 |
| Revenue This Year | $0.60 | $5.33 |
| Revenue Next Year | N/A | $3.07 |
| P/E Ratio | ★ $18.46 | $50.46 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $282.24 | $81.36 |
| 52 Week High | $741.98 | $128.29 |
| Indicator | DDS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 49.01 |
| Support Level | $680.93 | $98.73 |
| Resistance Level | $741.98 | $104.44 |
| Average True Range (ATR) | 25.84 | 2.97 |
| MACD | 1.54 | -0.44 |
| Stochastic Oscillator | 56.54 | 16.55 |
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.